RITA NWAJEI: Open Payments
NPI 1033723184 · ANGLETON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,608 in 75 payments from 18 companies in 2025. Trend: 2023 $1,348 · 2024 $2,779 · 2025 $2,608
Food & beverage: $2,608
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $442 |
| Amgen Inc. | 5 | $305 |
| Novo Nordisk Inc | 12 | $294 |
| Insulet Corporation | 4 | $262 |
| Lilly USA, LLC | 9 | $261 |
| Neurocrine BioSciences, Inc. | 5 | $188 |
| Dexcom, Inc. | 5 | $171 |
| Corcept Therapeutics | 5 | $107 |
| Ascendis Pharma Endocrinology Inc | 4 | $102 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $92 |
Products named: REZDIFFRA, Omnipod, Ozempic, CRENESSITY, JARDIANCE, TEPEZZA, EVENITY, ZEPBOUND.
Industry payments across TX — which companies pay providers there.
